1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cancer Drug Therapy Revenue
1.4 Market Analysis by Type
1.4.1 Global Cancer Drug Therapy Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Targeted Therapy
1.4.3 Chemotherapy
1.4.4 Immunotherapy
1.5 Market by Application
1.5.1 Global Cancer Drug Therapy Market Share by Application: 2021-2026
1.5.2 Angiogenesis Inhibitors
1.5.3 mTOR Inhibitors
1.5.4 Monoclonal Antibodies
1.5.5 Cytokine Immunotherapy (IL-2)
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Cancer Drug Therapy Market
1.8.1 Global Cancer Drug Therapy Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Cancer Drug Therapy Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Cancer Drug Therapy Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Cancer Drug Therapy Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Cancer Drug Therapy Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Cancer Drug Therapy Sales Volume Market Share by Region (2015-2020)
3.2 Global Cancer Drug Therapy Sales Revenue Market Share by Region (2015-2020)
3.3 North America Cancer Drug Therapy Sales Volume
3.3.1 North America Cancer Drug Therapy Sales Volume Growth Rate (2015-2020)
3.3.2 North America Cancer Drug Therapy Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Cancer Drug Therapy Sales Volume
3.4.1 East Asia Cancer Drug Therapy Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Cancer Drug Therapy Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Cancer Drug Therapy Sales Volume (2015-2020)
3.5.1 Europe Cancer Drug Therapy Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Cancer Drug Therapy Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Cancer Drug Therapy Sales Volume (2015-2020)
3.6.1 South Asia Cancer Drug Therapy Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Cancer Drug Therapy Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Cancer Drug Therapy Sales Volume (2015-2020)
3.7.1 Southeast Asia Cancer Drug Therapy Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Cancer Drug Therapy Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Cancer Drug Therapy Sales Volume (2015-2020)
3.8.1 Middle East Cancer Drug Therapy Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Cancer Drug Therapy Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Cancer Drug Therapy Sales Volume (2015-2020)
3.9.1 Africa Cancer Drug Therapy Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Cancer Drug Therapy Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Cancer Drug Therapy Sales Volume (2015-2020)
3.10.1 Oceania Cancer Drug Therapy Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Cancer Drug Therapy Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Cancer Drug Therapy Sales Volume (2015-2020)
3.11.1 South America Cancer Drug Therapy Sales Volume Growth Rate (2015-2020)
3.11.2 South America Cancer Drug Therapy Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Cancer Drug Therapy Sales Volume (2015-2020)
3.12.1 Rest of the World Cancer Drug Therapy Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Cancer Drug Therapy Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Cancer Drug Therapy Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Cancer Drug Therapy Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Cancer Drug Therapy Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Cancer Drug Therapy Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Cancer Drug Therapy Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Cancer Drug Therapy Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Cancer Drug Therapy Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Cancer Drug Therapy Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Cancer Drug Therapy Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Cancer Drug Therapy Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Cancer Drug Therapy Sales Volume Market Share by Type (2015-2020)
14.2 Global Cancer Drug Therapy Sales Revenue Market Share by Type (2015-2020)
14.3 Global Cancer Drug Therapy Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Cancer Drug Therapy Consumption Volume by Application (2015-2020)
15.2 Global Cancer Drug Therapy Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Cancer Drug Therapy Business
16.1 Amgen / Allergan
16.1.1 Amgen / Allergan Company Profile
16.1.2 Amgen / Allergan Cancer Drug Therapy Product Specification
16.1.3 Amgen / Allergan Cancer Drug Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Merck
16.2.1 Merck Company Profile
16.2.2 Merck Cancer Drug Therapy Product Specification
16.2.3 Merck Cancer Drug Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Aveo Pharmaceuticals
16.3.1 Aveo Pharmaceuticals Company Profile
16.3.2 Aveo Pharmaceuticals Cancer Drug Therapy Product Specification
16.3.3 Aveo Pharmaceuticals Cancer Drug Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Argos Therapeutics
16.4.1 Argos Therapeutics Company Profile
16.4.2 Argos Therapeutics Cancer Drug Therapy Product Specification
16.4.3 Argos Therapeutics Cancer Drug Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Incyte
16.5.1 Incyte Company Profile
16.5.2 Incyte Cancer Drug Therapy Product Specification
16.5.3 Incyte Cancer Drug Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 AstraZeneca
16.6.1 AstraZeneca Company Profile
16.6.2 AstraZeneca Cancer Drug Therapy Product Specification
16.6.3 AstraZeneca Cancer Drug Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Bristol-Myers Squibb
16.7.1 Bristol-Myers Squibb Company Profile
16.7.2 Bristol-Myers Squibb Cancer Drug Therapy Product Specification
16.7.3 Bristol-Myers Squibb Cancer Drug Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Exelixis
16.8.1 Exelixis Company Profile
16.8.2 Exelixis Cancer Drug Therapy Product Specification
16.8.3 Exelixis Cancer Drug Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Bayer
16.9.1 Bayer Company Profile
16.9.2 Bayer Cancer Drug Therapy Product Specification
16.9.3 Bayer Cancer Drug Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 Roche
16.10.1 Roche Company Profile
16.10.2 Roche Cancer Drug Therapy Product Specification
16.10.3 Roche Cancer Drug Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.11 Pfizer
16.11.1 Pfizer Company Profile
16.11.2 Pfizer Cancer Drug Therapy Product Specification
16.11.3 Pfizer Cancer Drug Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.12 Eisai
16.12.1 Eisai Company Profile
16.12.2 Eisai Cancer Drug Therapy Product Specification
16.12.3 Eisai Cancer Drug Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.13 Prometheus Labs
16.13.1 Prometheus Labs Company Profile
16.13.2 Prometheus Labs Cancer Drug Therapy Product Specification
16.13.3 Prometheus Labs Cancer Drug Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.14 Novartis
16.14.1 Novartis Company Profile
16.14.2 Novartis Cancer Drug Therapy Product Specification
16.14.3 Novartis Cancer Drug Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.15 Exelixis
16.15.1 Exelixis Company Profile
16.15.2 Exelixis Cancer Drug Therapy Product Specification
16.15.3 Exelixis Cancer Drug Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.16 Genentech (Roche)
16.16.1 Genentech (Roche) Company Profile
16.16.2 Genentech (Roche) Cancer Drug Therapy Product Specification
16.16.3 Genentech (Roche) Cancer Drug Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Cancer Drug Therapy Manufacturing Cost Analysis
17.1 Cancer Drug Therapy Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Cancer Drug Therapy
17.4 Cancer Drug Therapy Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Cancer Drug Therapy Distributors List
18.3 Cancer Drug Therapy Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Cancer Drug Therapy (2021-2026)
20.2 Global Forecasted Revenue of Cancer Drug Therapy (2021-2026)
20.3 Global Forecasted Price of Cancer Drug Therapy (2015-2026)
20.4 Global Forecasted Production of Cancer Drug Therapy by Region (2021-2026)
20.4.1 North America Cancer Drug Therapy Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Cancer Drug Therapy Production, Revenue Forecast (2021-2026)
20.4.3 Europe Cancer Drug Therapy Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Cancer Drug Therapy Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Cancer Drug Therapy Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Cancer Drug Therapy Production, Revenue Forecast (2021-2026)
20.4.7 Africa Cancer Drug Therapy Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Cancer Drug Therapy Production, Revenue Forecast (2021-2026)
20.4.9 South America Cancer Drug Therapy Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Cancer Drug Therapy Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Cancer Drug Therapy by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Cancer Drug Therapy by Country
21.2 East Asia Market Forecasted Consumption of Cancer Drug Therapy by Country
21.3 Europe Market Forecasted Consumption of Cancer Drug Therapy by Countriy
21.4 South Asia Forecasted Consumption of Cancer Drug Therapy by Country
21.5 Southeast Asia Forecasted Consumption of Cancer Drug Therapy by Country
21.6 Middle East Forecasted Consumption of Cancer Drug Therapy by Country
21.7 Africa Forecasted Consumption of Cancer Drug Therapy by Country
21.8 Oceania Forecasted Consumption of Cancer Drug Therapy by Country
21.9 South America Forecasted Consumption of Cancer Drug Therapy by Country
21.10 Rest of the world Forecasted Consumption of Cancer Drug Therapy by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer